pI: 4.5001 |
Length (AA): 277 |
MW (Da): 31245 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128044)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G55810 | bifunctional nicotinamide mononucleotide adenyltransferase and nicotinate-nucleotide adenylyltransferase |
Brugia malayi | Bm1_39780 | Chain A, Crystal Structure Of NmnNAMN ADENYLYLTRANSFERASE COMPLEXED With Nad. |
Brugia malayi | Bm1_36205 | Cytidylyltransferase family protein |
Candida albicans | CaO19.7499 | similar to S. cerevisiae YLR328W |
Caenorhabditis elegans | CELE_F26H9.4 | Protein NMAT-2 |
Caenorhabditis elegans | CELE_W06B3.1 | Protein NMAT-1 |
Dictyostelium discoideum | DDB_G0288757 | nicotinamide-nucleotide adenylyltransferase |
Drosophila melanogaster | Dmel_CG13645 | Nicotinamide mononucleotide adenylyltransferase |
Echinococcus granulosus | EgrG_001062300 | nicotinamide mononucleotide adenylyltransferase |
Entamoeba histolytica | EHI_084990 | nicotinamide nucleotide adenylyltransferase, putative |
Entamoeba histolytica | EHI_010950 | NMN adenylyltransferase, putative |
Echinococcus multilocularis | EmuJ_001062300 | nicotinamide mononucleotide adenylyltransferase |
Giardia lamblia | GL50803_92618 | Nicotinamide-nucleotide adenylyltransferase |
Giardia lamblia | GL50803_13672 | Nicotinamide-nucleotide adenylyltransferase |
Homo sapiens | ENSG00000163864 | nicotinamide nucleotide adenylyltransferase 3 |
Homo sapiens | ENSG00000173614 | nicotinamide nucleotide adenylyltransferase 1 |
Leishmania braziliensis | LbrM.17.1470 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_171450.1 | cytidylyltransferase, putative |
Leishmania infantum | LinJ.17.1450 | hypothetical protein, conserved |
Leishmania major | LmjF.17.1340 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.17.1340 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_01131 | cytidylyltransferase |
Loa Loa (eye worm) | LOAG_00727 | hypothetical protein |
Mus musculus | ENSMUSG00000032456 | nicotinamide nucleotide adenylyltransferase 3 |
Mus musculus | ENSMUSG00000046402 | retinol binding protein 1, cellular |
Mus musculus | ENSMUSG00000028992 | nicotinamide nucleotide adenylyltransferase 1 |
Oryza sativa | 4331124 | Os02g0814900 |
Onchocerca volvulus | OVOC535 | Nicotinamide mononucleotide adenylyltransferase 2 homolog |
Onchocerca volvulus | OVOC5082 | Nicotinamide mononucleotide adenylyltransferase 2 homolog |
Saccharomyces cerevisiae | YGR010W | nicotinamide-nucleotide adenylyltransferase NMA2 |
Saccharomyces cerevisiae | YLR328W | nicotinamide-nucleotide adenylyltransferase NMA1 |
Schistosoma mansoni | Smp_123490 | nicotinamide mononucleotide adenylyltransferase |
Schmidtea mediterranea | mk4.008055.00 | Nicotinamide mononucleotide adenylyltransferase 2 |
Trypanosoma brucei gambiense | Tbg972.5.3720 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.5.2640 | nicotinamide/nicotinic acid mononucleotide adenylyltransferase |
Trypanosoma congolense | TcIL3000_5_2680 | hypothetical protein, conserved |
Trypanosoma congolense | TcIL3000_5_2590 | cytidylyltransferase, putative |
Trypanosoma cruzi | TcCLB.507047.170 | cytidylyltransferase, putative |
Trypanosoma cruzi | TcCLB.509179.80 | cytidylyltransferase, putative |
Trichomonas vaginalis | TVAG_110480 | nicotinamide mononucleotide adenylyltransferase, putative |
Trichomonas vaginalis | TVAG_072070 | nicotinamide mononucleotide adenylyltransferase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.5.2640 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.2640 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.2640 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.5.2640 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F26H9.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 3 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.1
1 literature reference was collected for this gene.